Cannon-Brookes Michael

CEO Michael Cannon-Brookes sold 7,665 shares of TEAM for $783,970.42 on 2026-02-05; stock down 70.7% from 52-week high.

Michael Cannon-Brookes, CEO and Co-Founder, executed 8 separate sales totaling 7,665 shares for $783,970.42 on a single trading day (2026-02-05), reducing his holdings by 2.6% to 283.6K shares. The blended average price was $102.28, but the current price stands at $94.72—representing a 7.5% decline below the transaction price and a 70.7% decline from the 52-week high of $322.94. Notably, the stock has fallen 41.1% over the past 30 days and 40.0% over 90 days, and the company is unprofitable with net income of -$42.6M against revenue of $1.6B in the latest quarter. The CEO's sale into this steep drawdown environment—following 5 prior sales already filed on 2026-02-06—occurs at a price point significantly depressed from recent history and may signal limited conviction at current valuations.

CEO Michael Cannon-Brookes sells 7,665 shares at blended average $94.81 on 2026-02-06 for $726,715.67 total.

Michael Cannon-Brookes, CEO and Co-Founder, executed 9 separate sales totaling 7,665 shares for $726,715.67 on 2026-02-06 at a blended average price of $94.81, reducing his holdings from 283.6K shares to 275.9K shares (-2.7%). The sales occurred as the stock trades at $94.72 current price, down 70.7% from its 52-week high of $322.94 and down 41.1% over the past 30 days. The company is unprofitable with net income of -$42.6M against revenue of $1.6B, though it has achieved 19.7% annual revenue growth. The timing of this sale during a severe drawdown from historical highs, combined with the company's ongoing unprofitability despite revenue growth, warrants investor attention to whether the CEO's action signals changes in capital deployment priorities.

CEO Cannon-Brookes Michael sold 7,665 shares for $805,878.26 in 9 separate sales on 2026-02-04

Atlassian CEO Michael Cannon-Brookes executed 9 separate sales on 2026-02-04, totaling 7,665 shares for $805,878.26 at a blended average price of $105.14. The sale occurred during a pronounced market decline: the stock is currently trading at $98.41, down 69.5% from its 52-week high of $322.94 and down 37.9% over the past 30 days. The company generated $1,432,553,000.00 in revenue last quarter with 19.7% annual growth, but remains unprofitable with a net loss of $51,870,000.00 in its most recent full fiscal year. Post-transaction, Cannon-Brookes retained 291,270 shares, representing a 2.6% reduction in his prior holdings. His cross-ticker track record shows 20 prior sells, though timing outcomes are not disclosed for this specific transaction.

CEO Michael Cannon-Brookes sold 7,665 shares for $797,459.44 (blended avg $104.04) on 2026-02-03; stock down 67.5% from 52-week high

Michael Cannon-Brookes, CEO and Co-Founder, executed 8 separate sales totaling 7,665 shares for $797,459.44 at prices ranging from $101.62 to $109.31. Post-transaction holdings are 298,935 shares, representing a -2.5% reduction from pre-transaction levels. The sale occurred as TEAM trades 67.5% below its 52-week high of $322.94 and has declined 31.7% over 30 days and 32.7% over 90 days. Atlassian is currently unprofitable with $-51.9M net income on $1.4B quarterly revenue, though the company posted +19.7% annual revenue growth. The combination of significant recent stock depreciation, ongoing operating losses, and a large discretionary sale by the founder during a prolonged decline merits investor attention to the company's near-term operational trajectory and cash burn profile.

CEO Cannon-Brookes sells 7,665 shares for $892,193.70 at $116.40 avg; stock now 67.5% below 52-week high.

Michael Cannon-Brookes, CEO and Co-Founder of Atlassian, executed 6 separate sales totaling 7,665 shares for $892,193.70 on 2026-02-02 at a blended average price of $116.40. This represents a 2.4% reduction in his holdings from 314,265 to 306,600 shares. The sale occurred as TEAM trades at $105.00, down 67.5% from its 52-week high and 32.2% lower over the past 30 days. Atlassian remains unprofitable with net income of $-51,870,000.00 on revenue of $1,432,553,000.00 in its latest quarter, though the company posted annual revenue growth of 19.7%. The magnitude of the sale and timing amid significant stock weakness warrant attention to the price signal and Atlassian's path to profitability.

CEO Michael Cannon-Brookes sells 7,665 shares at blended avg $119.15 for $913,311.35; stock now -64.8% from 52-week high.

Michael Cannon-Brookes, CEO and Co-Founder, executed 5 separate sales totaling 7,665 shares for $913,311.35 on 2026-01-30, reducing his holdings by 2.4% to 314,265 shares. The sales occurred at prices ranging from $118.34 to $122.60, with a blended average of $119.15, while the stock has since declined 26.5% over the 30-day period and 31.1% over 90 days, now trading at $113.70—down 64.8% from its 52-week high of $322.94. The company remains unprofitable (net income $-51,870,000.00 on revenue of $1,432,553,000.00), though it maintains 19.7% annual revenue growth. This sale by the company's co-founder during a period of sustained stock weakness and operational losses warrants investor scrutiny of forward guidance and capital allocation plans.

CEO Cannon-Brookes sells 7,665 shares at $118.97 avg for $911.9K; stock down 63.4% from 52-week high

Michael Cannon-Brookes executed 6 separate sales totaling 7,665 shares for $911,894.72 on 2026-01-29, reducing his stake by 2.3% to 321,930 shares post-transaction. The sales occurred at prices ranging from $116.70 to $123.17, near the current market price of $118.18 but deeply depressed relative to the 52-week high of $322.94 (-63.4%). Atlassian remains unprofitable with negative net income of $-51,870,000 over its most recent full fiscal year, though the company delivered 19.7% annual revenue growth to $1,432,553,000. The timing of this CEO sale against a severely weakened stock price warrants investor attention to whether execution or structural headwinds are driving the valuation pressure.

Atlassian CEO Cannon-Brookes sold 7,665 shares for $1,038,152.64 on 2026-01-28; stock down 62.7% from 52-week high.

Cannon-Brookes executed 5 separate sales totaling 7,665 shares for $1,038,152.64 at a blended average price of $135.44, reducing holdings by 2.3% to 329,595 shares. The timing is notable: Atlassian's stock has fallen 62.7% from its 52-week high of $322.94 and declined 26.1% over the prior 30 days and 29.0% over 90 days, placing the transaction amid sharp downward momentum. The company posted $-51,870,000 net loss in its latest quarter despite 19.7% annual revenue growth, indicating profitability challenges. While his cross-ticker track record includes 20 prior sells, the outcome patterns at TEAM specifically remain unmeasurable—5 recent same-ticker sales occurred on 2026-01-29, the day after this filing, but lack 30- and 90-day return data. The sale size relative to his remaining 329,595-share position and the depressed valuation environment warrant attention to the underlying business fundamentals.

Atlassian CEO Cannon-Brookes sells 7,665 shares for $1.0M in 8 transactions at $133.30 blended average on 2026-01-27.

Cannon-Brookes executed 8 separate sales totaling 7,665 shares for $1,021,725.75 on a single day, reducing his stake by 2.2% to 337,260 shares post-transaction. The blended average price of $133.30 reflects deliberate execution across a range of prices from $132.04 to $139.47. The sale occurs as TEAM trades -58.3% from its 52-week high of $322.94 and -17.8% down over the prior 30 days, while the company remains unprofitable with full-year net income of $-51,870,000.00 despite 19.7% annual revenue growth to $1,432,553,000.00. His cross-ticker track record spans 20 prior sells; his same-ticker history at TEAM shows 5 prior trades, with no measurable outcomes yet at the 90-day horizon for recent activity. The transaction itself is material in size and represents a substantive disposition by the co-founder, warranting investor attention given the stock's recent weakness and company's unprofitable position.

CEO Michael Cannon-Brookes sold 7,665 shares at blended avg $136.93, raising $1.0M; stock now -58.6% from 52-week high.

Cannon-Brookes executed 6 separate sales totaling 7,665 shares for $1,049,586.63 on 2026-01-26, reducing his stake by -2.2% to 344,925 shares post-transaction. The sales occurred at prices ($134.51–$138.46) notably above the current price of $133.86, yet well below the 52-week high of $322.94. The stock has declined -18.0% over the prior 30 days and -16.0% over 90 days, placing it -58.6% from its peak. Atlassian remains unprofitable (net income $-51.9M in the latest full year) despite 19.7% annual revenue growth to $1.4B, creating a backdrop of operational losses during a period of equity drawdown by the co-founder.